The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic Information
Publication number:
EP3484477
WO Application Number:
US2017042011
Type:
European Patent Granted for NL
Status:
Deemed not to be granted according to art. 52.4a or 52.6 ROW
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP17828498.0
WO Publication Number:
WO2018013862
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
United States of America (US)
Publications:
Dates
Filing date:
13/07/2017
Grant date:
13/09/2023
EP Publication Date:
22/05/2019
WO Publication Date:
18/01/2018
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
13/09/2023
EP B1 Publication Date:
13/09/2023
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
12/07/2037
Lapsed By Expiration Date:
Revocation Date:
Invalidity Date:
13/09/2023
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:
Applicant/holder
From:
13/09/2023
Name:
Mingsight Pharmaceuticals, Inc.
Address:
P.O. Box 261208, San Diego, CA 92196, United States of America (US)
Inventor
1
Name:
NIESMAN, Michael
Address:
San Diego
California 92196, United States of America (US)
2
Name:
ZHANG, Kai
Address:
San Diego
California 92196, United States of America (US)